Paper Details

  1. Home
  2. Paper Details

Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.

Author: BarbaraL, BrillantiS, MiglioliM

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Standard interferon treatment for chronic hepatitis C is only successful in about 25% of patients. The effectiveness of retreatment or higher doses for patients who don’t respond or relapse has not been proven. A more effective treatment for hepatitis C that doesn't respond to interferon is needed.
Paper Details　
Original Abstract of the Article :
A sustained biochemical and virologic response to standard interferon therapy for chronic hepatitis C is seen in no more than 25% of patients, and the efficacy of re-treatment or of higher doses in non-responders and relapsers has not been established. A more effective therapy for interferon alfa-re...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/8720288

データ提供：米国国立医学図書館（NLM）

Fighting Hepatitis C: A Search for a More Effective Weapon

Hepatitis C, a viral infection that attacks the liver, can be a relentless foe. Imagine Hepatitis C as a relentless desert wind, eroding away at the liver. This research explores the effectiveness of combination antiviral therapy with ribavirin and interferon alfa for patients who have not responded to standard interferon therapy. Researchers are looking for a more effective weapon in the fight against this debilitating disease, a weapon that can truly stop the erosion and protect the liver.

A New Weapon in the Arsenal Against Hepatitis C

The study highlights the need for a more effective therapy for interferon alfa-resistant hepatitis C, a critical need in the fight against this persistent disease. This research provides a valuable step towards developing such therapies, potentially offering a new wave of hope for patients who have not responded to traditional treatments. It's like finding a new, sharper sword to combat this relentless enemy.

Protecting the Liver, Preserving the Oasis

Developing more effective therapies for hepatitis C is crucial for protecting the liver and preventing the development of serious complications. It's like building a wall of defense around the liver, protecting it from the relentless desert winds of the virus.

Dr. Camel's Conclusion

This research underscores the ongoing need for innovative therapies to combat hepatitis C. The search for a more effective weapon against this relentless disease continues, driven by the hope of finding a solution that can truly protect the liver and ensure a healthier future for patients.

Date :
  1. Date Completed 1996-10-11
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

8720288

DOI: Digital Object Identifier

8720288

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.